Urate Inhibitor Shows Promise in Gout - Medscape

Urate Inhibitor Shows Promise in Gout Medscape June 3, 2011 (London, United Kingdom) — Lesinurad added to allopurinol achieves rapid, sustained reductions in urate levels in patients with gout who have a suboptimal response to allopurinol alone. No safety concerns were raised in the randomized ...

EULAR: Novel Drug Effective for Refractory Gout - MedPage Today

EULAR: Novel Drug Effective for Refractory Gout MedPage Today Explain that an investigational uricosuric agent, lesinurad, in combination with allopurinol, significantly lowered serum urate in patients with refractory gout. LONDON -- Patients with refractory gout had ... BioCryst Presents New Analyses Of BCX4208 Phase 2 Studies In Patients With ...Medical News Today (press release) all 2 news articles »

EULAR: IL-1 Inhibitor Cuts Early Gout Flares - MedPage Today

MedPage Today

EULAR: IL-1 Inhibitor Cuts Early Gout Flares MedPage Today Note that uric acid-lowering therapy with allopurinol in patients with gout can elicit gout attacks during the initial months of therapy. Point out that this study suggests that rilonacept, an interleukin-1 blocker, is associated with a significant ...

Ardea Biosciences Presents Addl. Positive Data From Gout Drug Study - Update - RTT News

Ardea Biosciences Presents Addl. Positive Data From Gout Drug Study - Update RTT News Results presented from the ongoing extension portion of Ardea's Phase 2b study (study 203) of lesinurad in patients who did not achieve target on standard care allopurinol, showed patients who reached week 28 of the extension period, 91 percent of ... Ardea Biosciences Provides Additional Results From a Phase 2b Study of ...SYS-CON Media (press release) all 25 news articles »